Neptune Insurance Holdings Inc.
NP NYSE Insurance Agents, Brokers & Service Financials FY2023βFY2025
What Neptune Insurance Holdings Inc. does
No business description yet.
- Legal name
- Neptune Insurance Holdings Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0002067129-26-000007
0002067129
Revenue and margins
Neptune Insurance Holdings Inc. had $160M of revenue in fiscal 2025, up 33.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Neptune Insurance Holdings Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 11.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Neptune Insurance Holdings Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $24.3M | $7.1M | $8.0M |
| Debt incl. finance leases | β | $125M | $0.0M |
| Interest coverage | 2.1x | 3.9x | 3.9x |
| Current ratio | β | 0.7x | 1.0x |
| Quick ratio | β | 0.7x | 1.0x |
| Total assets | β | $48.2M | $65.3M |
| Total liabilities | β | $174M | $293M |
| Shareholders' equity | β$388M | β$366M | β$227M |
| Net debt (β = net cash) | β | $118M | β$8.0M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 4 | 5 / 8 |
| Accruals ratio | β | β31.8% | β25.1% |
| Altman Z'' | β | β19.28 | β19.23 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $84.9M | $119M | $160M |
| Operating income | $45.4M | $68.4M | $71.0M |
| Interest expense | $21.3M | $17.5M | $18.2M |
| Pretax income | $23.9M | $46.4M | $53.6M |
| Income tax | $6.0M | $11.8M | $16.2M |
| Net income | $17.9M | $34.6M | $37.4M |
| Net income to common | $9.8M | $14.7M | β$27.2M |
| Diluted EPS | $0.10 | $0.16 | β$0.26 |
| Diluted shares | 0.09B | 0.09B | 0.10B |
| Cash flow | |||
| Cash from operations | $18.6M | $49.9M | $51.7M |
| Stock-based compensation | $0.0M | $0.3M | $11.4M |
| Balance sheet | |||
| Cash and short-term investments | $24.3M | $7.1M | $8.0M |
| Total debt | β | $125M | $0.0M |
| Deposits | β | $11.8M | β |
| Current assets | β | $35.2M | $52.5M |
| Current liabilities | β | $48.6M | $52.8M |
| Goodwill | β | $3.8M | $3.8M |
| Intangible assets | β | $0.5M | $0.5M |
| Total assets | β | $48.2M | $65.3M |
| Total liabilities | β | $174M | $293M |
| Shareholders' equity | β$388M | β$366M | β$227M |
| Margins | |||
| Operating margin | 53.5% | 57.4% | 44.5% |
| Net margin | 21.1% | 29.0% | 23.4% |
| Returns | |||
| Return on capital employed | β | β16,532.9% | 567.4% |
| Return on assets | β | 71.8% | 66.0% |
| Growth | |||
| Revenue growth | β | 40.6% | 33.7% |
| Net income growth | β | 93.4% | 8.2% |
| EPS growth | β | 60.0% | β262.5% |
| Share count change | β | β0.2% | 11.9% |
| Financial health | |||
| Interest coverage | 2.1x | 3.9x | 3.9x |
| Current ratio | β | 0.7x | 1.0x |
| Quick ratio | β | 0.7x | 1.0x |
| Capital allocation | |||
| Stock comp / revenue | 0.0% | 0.2% | 7.2% |
| Quality scores | |||
| Piotroski F-score | β | β | 5.0 |
| Altman Z'' | β | β19.3 | β19.2 |
| Accruals ratio | β | β31.8% | β25.1% |
Source: SEC EDGAR XBRL filings (CIK 0002067129). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.